Drawing for VOIXNOSIS

USPTO serial 97743897

VOIXNOSIS

Reviewed by CopyMark Law Group

Reg. 7637570Status 700Registered
Filing date
Status date
Registration date
Jan 7, 2025
Examiner
BECKER, MARY ELIZABETH
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with VOIXNOSIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James J. Saul

James J. Saul FAEGRE DRINKER BIDDLE & REATH LLP320 South Canal Street, Suite 3300Chicago, IL 60606United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable and recorded computer software for the diagnosis of brain diseases; Downloadable and recorded computer software for use in testing in the field of brain diseases; Downloadable and recorded computer software for use in the field of neuropsychological testing; Downloadable and recorded computer operating system software; Recorded and downloadable electronic data files featuring information related to cognitive diseases and disorders; Downloadable multimedia file containing information in the nature of artwork, audio, video, text related to cognitive diseases and disorders; Downloadable and recorded computer software for the diagnosis of dementia; Downloadable and recorded computer software for use in testing for dementia; Downloadable and recorded computer software for use in testing for diseases and disorders; Downloadable and recorded computer software for diagnosing medical diseases and disorders; Downloadable and recorded computer software for use with medical apparatus and instruments; Downloadable and recorded computer software for early diagnosis and identification of dementia; Downloadable and recorded software for speech and voice recognition; Downloadable and recorded speech and voice recognition software using artificial intelligence; Electronic downloadable publications, namely, books, magazines, manuals for use by medical professionals in the field of science and medicine; Data collection apparatus for medical use in the nature of a data processing apparatus; Downloadable and recorded data processing software; Medical data transmission network routers; Diagnostic apparatus, namely, medical laboratory research measuring instruments for analyzing blood, body fluid, tissue or other biological samples not for medical purposes; Diagnostic apparatus in the nature of medical laboratory research instruments for non-medical purposes, namely, imaging machines for the diagnosis of cognitive disordersACTIVE—
010Telemetry apparatus for medical purposes; Medical instruments for diagnosing dementia which use speech and voice recognition software with artificial intelligence; Medical instruments for use in diagnosing of cognitive disorders using automatic response system; Medical apparatus and instruments for use in diagnosing of dementia using speech and voice recognition software with artificial intelligence; Medical apparatus and instruments for use in diagnosing of dementia using automatic response system; Telemetry apparatus for medical purposes, namely, telemetry devices relating to the diagnosis of dementia, Parkinson's disease and depressive disorder; Medical diagnostic instruments having automatic response function for monitoring and analyzing brain function; Medical diagnostic instruments having automatic response function for diagnosis and treatment of Mild Cognitive Impairment; Medical diagnostic instruments having automatic response function for the diagnosis of dementia and cognitive disorders; Medical diagnostic instruments having speech and voice recognition function for monitoring and analyzing brain function; Medical diagnostic instruments having speech and voice recognition function for diagnosis and treatment of Mild Cognitive Impairment; Medical diagnostic instruments having speech and voice recognition function for the diagnosis of dementia and cognitive disorders; Medical diagnostic and testing apparatus and instruments for diagnosing brain diseases, namely, neurodegenerative disease, cognitive disorders and mental illness in human beings; Medical diagnostic apparatus and instruments for use in diagnosis and treatment of cognitive disorders and neurological disorders; Diagnostic measuring apparatus for medical use for measuring neurophysiological signals; Medical apparatus and instruments in the field of clinical diagnosis, namely, apparatuses for analyzing brain wave frequencies and electroencephalographs; Medical apparatus and instruments in the fields of clinical diagnosis, namely, instruments for monitoring oxymetory, gas, analysis, and vital signs; Medical apparatus and instruments in the fields of clinical diagnosis, namely, biopsy instruments, and biopsy needles; Medical diagnostic apparatus for testing neurodegenerative conditions of the brain; Trace material analyzers for medical diagnostic uses; Test equipment for medical use, namely, medical diagnostic apparatus for testing body fluid samples; Medical apparatus and instruments for use in diagnosing of depressive disorders using speech and voice recognition software with artificial intelligence; Medical apparatus and instruments for use in diagnosing of Parkinson's disease using speech and voice recognition software with artificial intelligence; Medical apparatus and instruments for use in diagnosis and treatment of cognitive disorders and neurological disorders; Medical apparatus and instruments for use in diagnosis and treatment of dementia; Medical apparatus and instruments for use in diagnosis and treatment of neurodegenerative disease; Medical apparatus and instruments for use in diagnosis and treatment of Mild Cognitive ImpairmentACTIVE—
044Medical information services, namely, providing information relating to treatment of brain disease; Medical information services, namely, providing information relating to screening tests for dementia; Medical diagnostic services in the nature of medical testing for diagnostic purposes, using speech and voice recognition software with artificial intelligence; Medical examinations provided by use of automatic response software; Health care; Health counselling; Physical examination services; Providing healthcare services, namely, psychological therapy; Provision of psychological treatment; Consultancy relating to pharmaceutical and medical products for medical treatment use; Medical and health care services, namely, behavioral and mental health services; Medical examination services; Medical and surgical diagnostic services in the nature of medical testing for diagnostic and surgical purposes; Psychological testing for medical purposes; Medical information; Medical diagnostic services in the nature of medical testing for diagnostic purposes; Medical information services provided via the Internet; Mental health services; Medical diagnostic services in the nature of medical testing for diagnostic purposes, relating to brain diseaseACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 7, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 7, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 19, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 19, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 13, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 3, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Nov 3, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 3, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Nov 3, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 3, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 9, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 9, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 9, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 9, 2024ALIEASSIGNED TO LIE—
Jun 24, 2024ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Mar 25, 2024RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Mar 25, 2024GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Mar 25, 2024GNSIINQUIRY TO SUSPENSION E-MAILED—
Mar 25, 2024CNSISUSPENSION INQUIRY WRITTEN—
Sep 25, 2023GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Sep 25, 2023GNSLLETTER OF SUSPENSION E-MAILED—
Sep 25, 2023CNSLSUSPENSION LETTER WRITTEN—
Sep 15, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 15, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 15, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 15, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 15, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 15, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 13, 2023DOCKASSIGNED TO EXAMINER—
Jan 30, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 10, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance